APA Leads the way in Canine Parvovirus Treatment with Groundbreaking CPMA Implementation
The Animal Protective Association of Missouri (APA), an innovative leader in animal welfare, proudly announces the successful implementation of Canine Parvovirus Monoclonal Antibody (CPMA) treatment shortly after receiving conditional approval from the USDA. This implementation puts APA at the forefront of revolutionary and life-saving medicine for shelter pets.
CPMA, a one-time intravenous injection, has been granted conditional approval for use in Parvo-positive dogs as young as six weeks of age. This innovative treatment lessens the severity of symptoms associated with the illness.
In a recent study, dogs treated with CPMA exhibited significantly reduced symptoms, including less severe diarrhea, vomiting, fever, immunosuppression, and inappetence. Remarkably, none of the treated animals succumbed to Parvo during the study, starkly contrasting to the 57% mortality rate observed in the control group.
APA took its first strides in utilizing CPMA on Parvo-positive puppies on January 5, 2024. The initial patients, Oreo, Fudge Stripes, Chips Ahoy, Famous Amos, and Sugar Cookie, have all shown remarkable progress, being asymptomatic and testing negative for Parvo as of January 9, 2024. These resilient pups are now available for adoption, showcasing the transformative potential of CPMA.
Typically, Parvo takes several weeks for puppies to recover fully. With the introduction of CPMA, APA aims to significantly reduce the recovery period, improving the overall well-being of the affected animals.
“We are excited about this development for the veterinary community, and we are especially fortunate to be able to offer this groundbreaking treatment to our shelter animals,” said Dr. Garcia, DVM, Director of Veterinary Services at APA.
This pioneering initiative underscores APA’s unwavering commitment to advancing animal healthcare and welfare. In 2023, APA helped 6,313 dogs; this innovation will help us continue to serve all the dogs who need us. Additionally, with the introduction of CPMA, APA aims to significantly reduce the recovery period for Parvo cases, improving the overall well-being of the affected animals.